Author Correction To: In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations

Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-017-0599-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

DHA Inhibits ER Ca2+ Release and ER Stress in Astrocytes Following in Vitro Ischemia

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2012English

Author Correction: Caveolin-1 Impairs PKA-DRP1-mediated Remodelling of ER–mitochondria Communication During the Early Phase of ER Stress

Cell Death and Differentiation
Cell BiologyMolecular Biology
2019English

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines

PLoS ONE
Multidisciplinary
2012English

Design, Formulation and In-Vitro Evaluation of Sustained Release Tablet Formulations of Levosulpiride

Turkish Journal of Pharmaceutical Sciences
Molecular MedicinePharmaceutical Science
2018English

Correction: Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery

Cancer Discovery
Oncology
2019English

Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic Pain

Pain Practice
AnesthesiologyPain Medicine
2016English

Formulation and in Vitro Evaluation of Theophylline-Eudragit® Sustained-Release Tablets

Revista Brasileira de Ciências Farmacêuticas
2005English

Preparation and in Vitro Drug Release Evaluation of Curdlan Tablets.

Drug Delivery System
Pharmaceutical Science
1992English

Targeting Estrogen Receptor Subtypes (ER and ER ) With Selective ER Modulators in Ovarian Cancer

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy